Parent-implemented Social Communication Treatment in Autism
A Predict-to-Prescribe Approach to Social Communication Treatment in Chinese Preschool Children With Autism Spectrum Disorder
1 other identifier
interventional
112
2 countries
2
Brief Summary
An accumulation of research evidence has pointed to parent-implemented communication intervention as effective in reducing the severity of social communication deficits in autistic preschoolers. Despite even high-quality evidence, real-world translation to clinical practice remains challenging, especially for children from lower-income families, for two reasons. First, the intervention outcome is highly variable despite study-level efficacy data, most likely due to unique child and parent factors that make intervention response uneven across individual children. Second, the cost of intervention with the largest effect sizes remains high due to its one-on-one format. With the overarching goal to reduce cost and to increase intervention effectiveness at the individual-child level, this project will conduct a randomized controlled trial (RCT) to compare the effectiveness of two options for intervention to address two specific objectives. The investigators will first ascertain whether parent-implemented communication intervention taught by a speech therapist in a Group format (up to 8 families learning together) is more effective than intervention learnt by the parents themselves (learning the same materials without the guidance of a therapist) at the study level. The investigators will then evaluate what combinations of parent and child behavioral factors determine which format of intervention is likely to be more effective at the individual-child level. It is likely that not all families require the more costly Group format of intervention. Machine learning analytics with cross-validation will be used in constructing predictive models of intervention response, which will increase the likelihood of these models being generalizable to new patients. This study will be among the first examples of fulfilling the promise of Precision Medicine in providing guidance to patients and families with developmental disorders not about whether to receive intervention but which option for intervention to receive in the context of multiple options. This predict-to prescribe approach of autism intervention will likely lead to a paradigm shift in clinical practice and ultimately result in lowering the overall cost and increasing the effectiveness of intervention for autistic children as individuals.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Oct 2022
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2022
CompletedFirst Submitted
Initial submission to the registry
November 23, 2022
CompletedFirst Posted
Study publicly available on registry
December 2, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedJuly 1, 2025
June 1, 2025
2.2 years
November 23, 2022
June 27, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Autism severity change between baseline and 12 months
Comparing the pre- and post-intervention autism severity measured by comparison scores of Autism Diagnostic Observation Schedule™, Second Edition (ADOS-2) between groups. The ADOS-2 CSS ranges from 0 to 10; the higher the scores, the more severe the autism symptoms.
Baseline and 12 months after baseline
Social skill changes
Comparing the pre- and post-intervention social skills measured by the Social Affect score of Autism Diagnostic Observation Schedule™, Second Edition (ADOS-2), Social Communication Scale (SCS), and Vineland-3 between groups.
Baseline, immediately post-intervention (at 6 months), and 12 months after baseline
Expressive langauge changes
Comparing the pre- and post-intervention expressive language skills measured by the Mullen Scales of Early Learning (MSEL), the MLU transcribed from the Social Communication Scale (SCS), and Vineland-3 between groups.
Baseline, immediately post-intervention (at 6 months), and 12 months after baseline
Receptive language changes
Comparing the pre- and post-intervention receptive language skills measured by the Mullen Scales of Early Learning (MSEL), and Vineland-3 between groups.
Baseline, immediately post-intervention (at 6 months), and 12 months after baseline
Secondary Outcomes (3)
Parental stress changes
Baseline and immediately post-intervention (at 6 months)
Parental competence changes
Baseline and immediately post-intervention (at 6 months)
Parental strategy use changes
Baseline, immediately post-intervention (at 6 months), and 12 months after baseline
Study Arms (2)
Group-based Parent-implemented Social Communication Training
EXPERIMENTALEight parents learning in a group format and will be taught by a speech therapist online.
Self-learning-based Parent-implemented Social Communication Training
ACTIVE COMPARATORParents will learn the same materials without the guidance of a therapist.
Interventions
The intervention will be taught by a speech therapist online (approximately 25 hours distributed over 6 months), with up to 8 parents in a group.
Self-learning families will learn the same materials without the guidance of a therapist.
Eligibility Criteria
You may qualify if:
- Have a confirmed diagnosis of autism spectrum disorder or was evaluated to have elevated likelihood ("at-risk" or "suspected") by a Clinical Psychologist, Psychiatrist or Pediatrician who recommended continuous surveillance.
- Meet ADOS-2 criteria for autism or autism spectrum.
- Limited spontaneous expressive language, defined as producing two-to-three-word phrases or fewer, i.e., Autism Diagnostic Observation Schedule, Second Edition (ADOS-2) Module 2, Item A1 \> 0.
You may not qualify if:
- Mullen Scale of Early Learning non-verbal age at or less than 12 months
- Parent who has severe psychological or neurological conditions prohibiting them from conducting the intervention program at home (restricted to only the parent in the program)
- Children with any other severe developmental problems beyond autism spectrum disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Shenzhen Research Institute, The Chinese University of Hong Kong
Shenzhen, Guangdong, 518057, China
The Chinese University of Hong Kong
Hong Kong, Shatin, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Patrick CM Wong, PhD
Chinese University of Hong Kong
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Stanley Ho Professor of Cognitive Neuroscience; Director of Brain and Mind Institute
Study Record Dates
First Submitted
November 23, 2022
First Posted
December 2, 2022
Study Start
October 1, 2022
Primary Completion
November 30, 2024
Study Completion
December 30, 2025
Last Updated
July 1, 2025
Record last verified: 2025-06
Data Sharing
- IPD Sharing
- Will not share